References
- Mahapatra DK, Bharti SK, Asati V. Anti-cancer chalcones: structural and molecular target perspectives. Eur J Med Chem 2015;98:69–114.
- Bray F, Møller B. Predicting the future burden of cancer. Nat Rev Cancer 2006;6:63–74.
- Cragg GM, Newman DJ. Nature: a vital source of leads for anticancer drug development. Phytochem Rev 2009;8:313–31.
- Fujita E, Nagao Y, Kaneko K, et al. The antitumor and antibacterial activity of the Isodon diterpenoids. Chem Pharm Bull (Tokyo) 1976; 24:2118–27.
- Bohanon FJ, Wang XF, Ding CY, et al. Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis. J Surg Res 2014;190:55–63.
- Bohanon FJ, Wang XF, Graham BM, et al. Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis. J Surg Res 2015;199:441–9.
- Bohanon FJ, Wang XF, Graham BM, et al. Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 for hepatic stellate cells. Mol Cell Biochem 2015;410:293–300.
- Wang SL, Yang H, Yu LJ, et al. Oridonin attenuates Aβ1–42-induced neuroinflammation and inhibits NF-κB pathway. PLoS One 2014;9:e104745.
- Xu ST, Pei LL, Li DH, et al. Synthesis and anti-mycobacterial evaluation of natural oridonin and its enmein-type derivatives. Fitoterapia 2014;99:300–6.
- Ku CM, Lin JY. Anti-inflammatory effects of 27 selected terpenoid compounds tested through modulating Th1/Th2 cytokine secretion profiles using murine primary splenocytes. Food Chem 2013;141:1104–13.
- Xu ST, Yao H, Luo SS, et al. A novel potent anticancer compound optimized from a natural oridonin scaffold induces apoptosis and cell cycle arrest through the mitochondrial pathway. J Med Chem 2017;60:1449–68.
- Ding CY, Zhang YS, Chen HJ, et al. Oridonin ring A-based diverse constructions of enone functionality: identification of novel dienone analogues effective for highly aggressive breast cancer by inducing apoptosis. J Med Chem 2013;56:8814–25.
- Xu ST, Pei LL, Wang CQ, et al. Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates. ACS Med Chem Lett 2014;5:797–802.
- Li DH, Han T, Tian HT, et al. Novel nitric oxide-releasing spirolactone-type diterpenoid derivatives with in vitro synergistic anticancer activity as apoptosis inducer. Bioorg Med Chem Lett 2016;26:4191–6.
- Li DH, Xu ST, Cai H, et al. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: synthesis and their antitumor biological evaluation. Eur J Med Chem 2013;64:215–21.
- Ding CY, Wang LL, Chen HJ, et al. ent-Kaurane-based regio-and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids. Org Biomol Chem 2014;12:8442.
- Li DH, Xu ST, Cai H, et al. Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents. ChemMedChem 2013;8:812–18.
- Xu W, Sun J, Zhang TT, et al. Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma. Acta Pharmacol Sin 2006;27:1642–6.
- Rao Vadaparthi PR, Pavan Kumar C, Kumar K, et al. Synthesis of costunolide derivatives by Pd-catalyzed Heck arylation and evaluation of their cytotoxic activities. Med Chem Res 2015;24:2871–8.
- Zhang J, Ji F, Gu Y, et al. Chalcones derivatives as potent cell division cycle 25B phosphatase inhibitors. Pharmacol Rep 2014;66:515–19.
- Coskun D, Erkisa M, Ulukaya E, et al. Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: synthesis, characterization and anticancer activity. Eur J Med Chem 2017;136:212–22.
- Patrick TB, Agboka TY, Gorrell K. Heck reaction with 3-fluoro-3-buten-2-one. J Fluorine Chem 2008;129:983–5.
- Liu CF, Shen QK, Li JJ, et al. Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one-linked to triazole moieties as potent cytotoxic agents. J Enzyme Inhib Med Chem 2017;32:1111–19.
- Zhou HY, Dong FQ, Du XL, et al. Antitumor activities of biscoumarin and dihydropyran derivatives. Bioorg Med Chem Lett 2016;26:3876–80.
- Hileman EO, Liu J, Albitar M, et al. Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol 2004;53:209–19.
- Luo GS, Muyaba M, Lyu W, et al. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents. Bioorg Med Chem Lett 2017;27:867–74.